FDG-PET Scanning Has a Limited Role in the Management of Low and Intermediate Grade Neuroendocrine Tumors of Lung

被引：0
|
作者：
Feczko, A. [1 ]
Cattoni, M. [1 ]
Vallieres, E. [1 ]
Brown, L. [2 ]
Sarkeshik, A. [2 ]
Margaritora, S. [3 ]
Siclliani, A. [3 ]
Filosso, P. L. [4 ]
Guerrera, F. [4 ]
Siclliani, A. Alessandra [5 ]
Rotolo, N. [5 ]
Farjah, F. [6 ]
Wandell, G. [6 ]
Costas, K. [7 ]
Mann, C. [1 ]
Hubka, M. [8 ]
Kaplan, S. [8 ]
Wilshire, C. [1 ]
Farivar, A. [1 ]
Aye, R. [1 ]
Louie, B. [1 ]
机构：
[1] Swedish Med Ctr, Thorac Surg, Seattle, WA USA
[2] UC Davis Med Ctr, Sect Gen Thorac Surg, Dept Surg, Sacramento, CA USA
[3] Univ Cattolica Sacro Cuore, Unit Thorac Surg, Rome, Italy
[4] Univ Torino Italy, Sug Sci, Turin, Italy
[5] Univ Insurbria, Osped Circolo, Ctr Thorac Surg, Varese, Italy
[6] Univ Washington, Div Cardiothorac Surg, Med Ctr, Seattle, WA 98195 USA
[7] Providence Reg Med Ctr, Div Thorac Surg, Everett, WA USA
[8] Virginia Mason Hosp & Seattle Med Ctr, Div Thorac Surg, Seattle, WA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Positron emission testing imaging; Neuroendocrine tumor;
D O I：
10.1016/j.jtho.2017.09.1902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB039
引用
收藏
页码：S2378 / S2378
页数：1
相关论文
共 50 条
  • [1] Value of FDG-PET scanning in management of lung cancer
    Coleman, RE
    LANCET, 2002, 359 (9315): : 1361 - 1362
  • [2] Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors
    Perrier, Marine
    Hentic, Olivia
    Walter, Thomas
    Cao, Christine Do
    Cadiot, Guillaume
    de Mestier, Louis
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (12) : 1521 - 1524
  • [3] Role and indications of fluorodeoxyglucose positron emission tomography (FDG-PET) in neuroendocrine pancreaticoduodenal tumors
    Sperti, C
    Scappin, S
    Chierichetti, F
    Liessi, G
    Pedrazzoli, S
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 43 - 43
  • [4] FDG-PET Scanning has a High Impact on the Management of Patients With Merkel Cell Carcinoma
    Siva, S.
    Byrne, K.
    Seel, M.
    Bressel, M.
    Jacobs, D.
    Callahan, J.
    Laing, J.
    MacManus, M.
    Hicks, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S136 - S136
  • [5] Low Grade neuroendocrine Tumors of the Lung
    Melosky, Barbara
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [6] FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer
    Arens, Anne I. J.
    Postema, Jan W. A.
    Schreurs, Wendy M. J.
    Lafeber, Albert
    Hendrickx, Baudewijn W.
    Oyen, Wim J. G.
    Vogel, Wouter V.
    PLOS ONE, 2016, 11 (08):
  • [7] Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors: is there a role for FDG-PET in predicting response to treatment?
    Severi, S.
    Sansovini, M.
    Bodei, L.
    Milandri, C.
    Ambrosetti, A.
    Galassi, R.
    Annunziata, F.
    Scarpi, E.
    Monti, M.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S116 - S116
  • [8] Role of FDG-PET and FDG-PET/CT in the management of hepatic tumors treating th Yttrium-90 radm-embolizatmn
    Seraj, Siavash Mehdizadeh
    Kothekar, Esha
    Rojulpote, Chaitanya
    Werner, Thomas
    Alavi, Abass
    Hunt, Stephen
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [9] Prognostic Role of FDG-PET in Advanced Digestive Neuroendocrine Neoplasms
    Rinzivillo, M.
    Panzuto, F.
    Capurso, G.
    Prosperi, D.
    Pizzichini, P.
    Cicchese, N.
    Merola, E.
    Schillaci, O.
    Scopinaro, F.
    Delle Fave, G.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 115 - 115
  • [10] The use of FDG-PET scanning (PET) in the management of merkel cell carcinoma
    Bedi, C.
    Seel, M.
    Ramdave, S.
    Hicks, R.
    MacManus, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S107 - S107
12345